Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Pathward Financial
CASH
$1.69B
| $21.4M | ﹤0.01% |
245,918
+7,964
| +3% | +$689K |
|
|
DFTX
3027
Definium Therapeutics
DFTX
$5.51B
| $21.4M | ﹤0.01% |
454,912
+16,339
| +4% | +$404K |
|
3028
BlackRock Multi-Sector Income Trust
BIT
$682M
| $21.4M | ﹤0.01% |
1,708,261
+343,666
| +25% | +$4.33M |
|
3029
CVR Energy
CVI
$4.2B
| $21.4M | ﹤0.01% |
776,040
+6,545
| +0.9% | +$208K |
|
3030
Liberty Media Series A
FWONA
$23.4B
| $21.3M | ﹤0.01% |
243,856
+37,796
| +18% | +$3.11M |
|
3031
CTS Corp
CTS
$1.62B
| $21.3M | ﹤0.01% |
326,843
-7,962
| -2% | -$478K |
|
3032
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$262M
| $21.3M | ﹤0.01% |
466,103
-33,722
| -7% | -$1.58M |
|
3033
Dentsply Sirona
XRAY
$2.22B
| $21.3M | ﹤0.01% |
2,004,305
-413,355
| -17% | -$4.51M |
|
3034
Goosehead Insurance
GSHD
$1.7B
| $21.3M | ﹤0.01% |
438,286
+115,278
| +36% | +$4.76M |
|
3035
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.86B
| $21.3M | ﹤0.01% |
355,019
-9,428
| -3% | -$579K |
|
3036
Nuveen Real Asset Income & Growth Fund
JRI
$339M
| $21.2M | ﹤0.01% |
1,638,606
+20,221
| +1% | +$260K |
|
3037
Atlas Energy Solutions
AESI
$1.61B
| $21.2M | ﹤0.01% |
1,273,572
+369,910
| +41% | +$6.05M |
|
3038
Summit Therapeutics
SMMT
$11B
| $21.1M | ﹤0.01% |
1,450,019
-200,572
| -12% | -$3.56M |
|
|
CMBT
3039
CMB.TECH NV
CMBT
$5.32B
| $21.1M | ﹤0.01% |
1,509,906
-54,157
| -3% | -$780K |
|
|
NCV
3040
Virtus Convertible & Income Fund
NCV
$380M
| $21.1M | ﹤0.01% |
1,200,261
-104,094
| -8% | -$1.76M |
|
3041
Minerals Technologies
MTX
$2.24B
| $21.1M | ﹤0.01% |
285,367
+11,047
| +4% | +$834K |
|
3042
Enovix
ENVX
$737M
| $21.1M | ﹤0.01% |
3,470,634
+1,658,688
| +92% | +$11M |
|
3043
iShares Russell Top 200 Value ETF
IWX
$4.04B
| $21M | ﹤0.01% |
200,112
+4,771
| +2% | +$483K |
|
3044
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$599M
| $21M | ﹤0.01% |
2,018,327
+32,255
| +2% | +$333K |
|
3045
Goodyear
GT
$1.83B
| $21M | ﹤0.01% |
3,183,417
-1,470,146
| -32% | -$9.46M |
|
3046
Atlanta Braves Holdings Series B
BATRK
$3.24B
| $21M | ﹤0.01% |
404,446
+52,007
| +15% | +$2.55M |
|
3047
State Street SPDR S&P Capital Markets ETF
KCE
$488M
| $20.9M | ﹤0.01% |
142,242
-13,149
| -8% | -$1.98M |
|
|
FTW
3048
Presidio Production Co
FTW
$353M
| $20.9M | ﹤0.01% |
1,721,020
+3,629
| +0.2% | +$41.5K |
|
3049
Invesco China Technology ETF
CQQQ
$3.07B
| $20.9M | ﹤0.01% |
366,945
+207,047
| +129% | +$10.7M |
|
|
VOYG
3050
Voyager Technologies
VOYG
$2.09B
| $20.9M | ﹤0.01% |
648,593
+239,807
| +59% | +$8.3M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.